---
title: "Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263374794.md"
description: "Cyclo Therapeutics' TransportNPC™ Phase 3 clinical trial for Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C1, a rare and fatal genetic disease, is continuing at the recommendation of the Data Monitoring Committee ( DMC ) following their review of prespecified safety and ..."
datetime: "2025-10-29T21:07:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263374794.md)
  - [en](https://longbridge.com/en/news/263374794.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263374794.md)
generator: "portal-rs"
---

# Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results

Cyclo Therapeutics' TransportNPC™ Phase 3 clinical trial for Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C1, a rare and fatal genetic disease, is continuing at the recommendation of the Data Monitoring Committee ( DMC ) following their review of prespecified safety and ...

### Related Stocks

- [CYTH.US](https://longbridge.com/en/quote/CYTH.US.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**